Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 10 | 2014 | 683 | 1.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2024 | 933 | 0.920 |
Why?
|
| Exons | 1 | 2024 | 91 | 0.880 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 239 | 0.820 |
Why?
|
| Carcinoma | 1 | 2024 | 106 | 0.790 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 310 | 0.730 |
Why?
|
| Interleukins | 1 | 2014 | 37 | 0.440 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2007 | 130 | 0.330 |
Why?
|
| Base Pair Mismatch | 1 | 2007 | 15 | 0.270 |
Why?
|
| DNA Probes | 1 | 2007 | 33 | 0.270 |
Why?
|
| Transcription, Genetic | 4 | 2009 | 599 | 0.270 |
Why?
|
| Lung Neoplasms | 5 | 2007 | 479 | 0.270 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 57 | 0.270 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 55 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 4 | 2024 | 534 | 0.260 |
Why?
|
| Microdissection | 2 | 2012 | 13 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2024 | 190 | 0.250 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 158 | 0.240 |
Why?
|
| Neoplasms | 3 | 2005 | 1341 | 0.240 |
Why?
|
| Drug Therapy | 1 | 2005 | 17 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 508 | 0.230 |
Why?
|
| Stem Cells | 1 | 2006 | 151 | 0.230 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 53 | 0.230 |
Why?
|
| Chromosomes | 2 | 2024 | 44 | 0.220 |
Why?
|
| Nanomedicine | 1 | 2005 | 52 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2598 | 0.220 |
Why?
|
| Lasers | 1 | 2004 | 57 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 303 | 0.210 |
Why?
|
| Algorithms | 1 | 2007 | 508 | 0.210 |
Why?
|
| Protein Isoforms | 1 | 2024 | 139 | 0.210 |
Why?
|
| Humans | 20 | 2024 | 42163 | 0.200 |
Why?
|
| RNA, Messenger | 5 | 2014 | 1265 | 0.200 |
Why?
|
| Binding Sites | 1 | 2024 | 670 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 273 | 0.190 |
Why?
|
| Breast | 1 | 2024 | 139 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 158 | 0.190 |
Why?
|
| Prostatic Neoplasms | 3 | 2009 | 1068 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 255 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 228 | 0.180 |
Why?
|
| RNA | 3 | 2008 | 266 | 0.180 |
Why?
|
| Membrane Proteins | 1 | 2003 | 548 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 979 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 928 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 1058 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2012 | 187 | 0.110 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 79 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2014 | 103 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 11 | 0.100 |
Why?
|
| DNA Primers | 3 | 2007 | 295 | 0.100 |
Why?
|
| Female | 4 | 2024 | 24018 | 0.090 |
Why?
|
| Base Sequence | 3 | 2007 | 997 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 137 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2006 | 722 | 0.080 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2009 | 11 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2009 | 31 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 649 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 91 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 84 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2009 | 77 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 129 | 0.070 |
Why?
|
| Microfluidics | 1 | 2008 | 45 | 0.070 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2007 | 9 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2007 | 54 | 0.070 |
Why?
|
| Epithelium | 1 | 2007 | 78 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 30 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 45 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 271 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2007 | 34 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 143 | 0.070 |
Why?
|
| HMGB Proteins | 1 | 2006 | 2 | 0.060 |
Why?
|
| Genes, Developmental | 1 | 2006 | 2 | 0.060 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2006 | 11 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2006 | 19 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 154 | 0.060 |
Why?
|
| Mice | 3 | 2007 | 6490 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 64 | 0.060 |
Why?
|
| Genome, Human | 2 | 2007 | 143 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 602 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 144 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 223 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 1188 | 0.060 |
Why?
|
| Robotics | 1 | 2005 | 42 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1559 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 383 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1066 | 0.050 |
Why?
|
| RNA Probes | 1 | 2003 | 11 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 183 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 134 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2003 | 75 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 230 | 0.050 |
Why?
|
| Chromatin | 1 | 2004 | 179 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 557 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 222 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 330 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 378 | 0.050 |
Why?
|
| Animals | 4 | 2007 | 16695 | 0.050 |
Why?
|
| Neurons | 2 | 2007 | 1246 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2004 | 393 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 661 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1617 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 1679 | 0.030 |
Why?
|
| Male | 4 | 2009 | 22779 | 0.030 |
Why?
|
| Prognosis | 2 | 2010 | 850 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 1416 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 14 | 0.020 |
Why?
|
| Lung | 2 | 2004 | 484 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2010 | 23 | 0.020 |
Why?
|
| Ultrasonography, Mammary | 1 | 2010 | 8 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2010 | 17 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 53 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 174 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 236 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 93 | 0.020 |
Why?
|
| Mitogens | 1 | 2009 | 10 | 0.020 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2009 | 7 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2009 | 41 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 353 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 366 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 246 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2008 | 18 | 0.020 |
Why?
|
| Mammography | 1 | 2010 | 211 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2008 | 28 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2008 | 84 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 40 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 195 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 170 | 0.020 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2007 | 1 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 661 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2007 | 40 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2007 | 36 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1054 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 845 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 421 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 51 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 67 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 61 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2008 | 196 | 0.020 |
Why?
|
| Purines | 1 | 2007 | 40 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 577 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2007 | 55 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 81 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 55 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 167 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 201 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 916 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 526 | 0.020 |
Why?
|
| Histones | 1 | 2007 | 194 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 427 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 159 | 0.020 |
Why?
|
| Cattle | 1 | 2007 | 505 | 0.010 |
Why?
|
| Ligands | 1 | 2007 | 387 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2007 | 170 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 452 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 522 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 436 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 18 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 382 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 45 | 0.010 |
Why?
|
| Quality Control | 1 | 2004 | 41 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 76 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2004 | 29 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2004 | 46 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 973 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 154 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 2111 | 0.010 |
Why?
|
| Prostate | 1 | 2004 | 152 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 183 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 383 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 1131 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3942 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 884 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 105 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 287 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 206 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 1729 | 0.010 |
Why?
|
| United States | 1 | 2010 | 5072 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1848 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 3701 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 2803 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 7982 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 11819 | 0.000 |
Why?
|
| Adult | 1 | 2004 | 13458 | 0.000 |
Why?
|